CD47 and gastric cancer: To accurately and authentically forecast the efficacy of anti-CD47 immunotherapy on human gastric cancer, we developed Hu-PDX models that maintained the attributes of the original tumors and provided a more accurate representation of the pertinent constituents and interactions within the TME.